Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 Y-mAbs Therapeutics, Inc. YMAB May 27, 2022 11.66 +6.19   
 Yalla Group Limited YALA May 27, 2022 3.76 +6.52   
 Yamana Gold Inc. AUY May 27, 2022 5.17 -0.96   
 Yandex N.V. - Class A Ordinary Shares YNDX May 27, 2022 18.94 0.00   
 Yatra Online, Inc. - Ordinary Shares YTRA May 27, 2022 1.79 +3.47   
 Yatsen Holding Ltd YSG May 27, 2022 0.49 +8.51   
 Yellow Corporation YELL May 27, 2022 3.80 +0.53   
 Yelp Inc. YELP May 27, 2022 30.45 +3.33   
 YETI Holdings, Inc. YETI May 27, 2022 46.11 +1.72   
 Yext, Inc. YEXT May 27, 2022 5.17 +3.61   
 Yield10 Bioscience, Inc. YTEN May 27, 2022 2.85 +5.17   
 Yieldshares High Income ETF YYY May 27, 2022 13.78 +1.62   
 Yiren Digital Ltd YRD May 27, 2022 1.75 +5.42   
 Youdao, Inc. American Depositary Shares, each representing o DAO May 27, 2022 4.82 +3.43   
 YPF Sociedad Anonima YPF May 27, 2022 4.66 +2.64   
 Yum China Holdings, Inc. YUMC May 27, 2022 43.23 +0.46   
 Yum! Brands, Inc. YUM May 27, 2022 119.77 +1.71   
 Yumanity Therapeutics, Inc. YMTX May 27, 2022 1.10 +0.92   
 Yunhong CTI Ltd. CTIB May 27, 2022 0.84 +2.06   
 Yunji Inc. - American Depository Shares YJ May 27, 2022 1.16 +12.62   
 Z-Work Acquisition Corp. - Class A ZWRK May 27, 2022 9.80 +0.26   
 Z-Work Acquisition Corp. - Units ZWRKU May 27, 2022 9.85 0.00   
 Zai Lab Limited - American Depositary Shares ZLAB May 27, 2022 29.90 -0.33   
 Zanite Acquisition Corp. - Class A ZNTE May 27, 2022 11.32 0.00   
 Zanite Acquisition Corp. - Unit ZNTEU May 27, 2022 11.53 0.00   
 ZC SP ETN REDEEM 19/07/2050 USD 25 - Ser B AMND May 27, 2022 41.33 +1.26   
 ZC SP ETN REDEEM 20/10/2050 USD 25 - Series B AMTR May 27, 2022 50.36 +1.32   
 Zealand Pharma A/S - American Depositary Shares ZEAL May 27, 2022 13.94 +1.01   
 Zebra Technologies Corporation - Class A ZBRA May 27, 2022 343.53 +3.33   
 Zedge, Inc. Class B ZDGE May 27, 2022 5.26 +4.37   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+